Actively Recruiting
Early-phase Schizophrenia: Practice-based Research to Improve Outcomes (ESPRITO) - Using Artificial Intelligence to Measure Adherence to Oral Medication
Led by Northwell Health · Updated on 2024-09-19
200
Participants Needed
5
Research Sites
4 weeks
Total Duration
On this page
Sponsors
N
Northwell Health
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a smartphone app that uses artificial intelligence (AI) to support medication adherence in people experiencing their first episode of psychosis. The study aims to see how acceptable the app is to patients and to compare hospitalization and emergency room visit rates between those using the app and those receiving standard care. This research addresses the significant challenge of monitoring and improving oral medication adherence in this population, which is linked to better clinical outcomes. Participants are randomly assigned to one of two groups: one group uses the AI smartphone app designed to help with oral medication adherence, while the other group receives usual care provided by the Coordinated Specialty Care (CSC) clinic. The app offers a novel way to support and monitor medication adherence that is more feasible in community settings than traditional methods like direct observation. During the study, researchers will track participants' healthcare service usage over 12 months, focusing on hospitalizations and emergency visits. Participants' acceptability of the AI app will also be assessed based on their engagement in the study. The study runs from November 2020 through December 2024 and involves adults aged 15 to 40 years diagnosed with first episode psychosis. This includes monitoring through service utilization reports and comparisons of outcomes between the two groups.
CONDITIONS
Brief Title
Artificial Intelligence to Measure Adherence to Oral Medication
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Enrolled in a Coordinated Specialty Care (CSC) program
- Prescribed an oral antipsychotic
- Aged between 15 and 40 years
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 months
Participants use either the artificial intelligence smartphone app to support medication adherence or receive usual care provided at the Coordinated Specialty Care clinic.
Trial Site Locations
Total: 5 locations
1
Citrus Health
Hialeah, Florida, United States, 33012
Actively Recruiting
2
InterAct
Grand Rapids, Michigan, United States, 49503
Actively Recruiting
3
InterAct of Michigan
Kalamazoo, Michigan, United States, 49007
Actively Recruiting
4
Red Rock
Oklahoma City, Oklahoma, United States, 73105
Actively Recruiting
5
Family and Children's Services
Tulsa, Oklahoma, United States, 74315
Actively Recruiting
Research Team
P
Patricia Marcy, BSN
C
Cristina Gonzalez, MS
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here